• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全身性抗真菌药物。

Systemic antifungal agents.

作者信息

Abuhammour W, Habte-Gabr E

机构信息

Department of Pediatrics, Hurley Medical Centre, Michigan State University-College of Human Medicine, Flint, Michigan, USA.

出版信息

Indian J Pediatr. 2001 Jul;68(7):655-68. doi: 10.1007/BF02752281.

DOI:10.1007/BF02752281
PMID:11519290
Abstract

Anti-fungal agents are classified under two major headings, systematic and topical agents. Only systematic anti-fungal agents will be discussed in this chapter. Since the discovery in 1955, amphotericin B has been the cornerstone of anti-fungal treatment. It is active against most species of fungi. However, Candida lusitaniae, Pseudallescheria boydii, and fusarium spp have primary resistance to amphotericin B. Recently, new liposomal preparations of amphotericin B have been developed. They are less nephrotoxic. The azole family of anti-fungal includes two broad classes: the imidazoles (clotrimazote, ketoconazote, miconazole) and the triazoles (flucouazole and itracouazole). Imidazoles are still widely used for the treatment of superficial mycoses and vaginal candidiasis. The systematic triazoles are more slowly metabolized and have less effect on human synthesis than imidazoles, hence they are preferred for systemic therapy. Flucytosine is a fluorinated pyrimidine. Clinically, the principal use of flucytosine is as adjunctive therapy with amphotericin B in the treatment of candidial or cryptococcal diseases, Griseofuluin is derived from penicillium. It is fungistatic in vitro for species of dermatophytes. It is useful for the treatment of tinea capitis and tinea unginum.

摘要

抗真菌药物分为两大类,即全身用药和局部用药。本章仅讨论全身用抗真菌药物。自1955年发现以来,两性霉素B一直是抗真菌治疗的基石。它对大多数真菌种类都有活性。然而,葡萄牙念珠菌、波氏假阿利什霉和镰刀菌属对两性霉素B具有原发性耐药性。最近,已开发出两性霉素B的新型脂质体制剂。它们的肾毒性较小。抗真菌唑类家族包括两大类:咪唑类(克霉唑、酮康唑、咪康唑)和三唑类(氟康唑和伊曲康唑)。咪唑类仍广泛用于治疗浅表真菌病和阴道念珠菌病。与咪唑类相比,全身性三唑类代谢较慢,对人体合成的影响较小,因此它们更适合用于全身治疗。氟胞嘧啶是一种氟化嘧啶。临床上,氟胞嘧啶的主要用途是与两性霉素B联合治疗念珠菌病或隐球菌病。灰黄霉素源自青霉菌。它在体外对皮肤癣菌具有抑菌作用。它可用于治疗头癣和股癣。

相似文献

1
Systemic antifungal agents.全身性抗真菌药物。
Indian J Pediatr. 2001 Jul;68(7):655-68. doi: 10.1007/BF02752281.
2
Antifungal agents used for deep-seated mycotic infections.用于深部真菌感染的抗真菌药物。
Mayo Clin Proc. 1987 Dec;62(12):1116-28. doi: 10.1016/s0025-6196(12)62506-3.
3
Antifungal agents used in systemic mycoses. Activity and therapeutic use.用于全身性真菌病的抗真菌药物。活性与治疗用途。
Drugs. 1983 Jan;25(1):41-62. doi: 10.2165/00003495-198325010-00003.
4
Antifungal agents used for deep-seated mycotic infections.
Mayo Clin Proc. 1983 Apr;58(4):223-31.
5
[New pharmaceuticals in systemic mycoses (author's transl)].全身性真菌病的新型药物(作者译)
Z Hautkr. 1981 Sep 1;56(17):1109-25.
6
Antifungal agents used for deep-seated mycotic infections.用于深部真菌感染的抗真菌药物。
Mayo Clin Proc. 1992 Jan;67(1):69-91. doi: 10.1016/s0025-6196(12)60281-x.
7
Liposomal amphotericin B: what is its role in 2008?脂质体两性霉素B:2008年它的作用是什么?
Clin Microbiol Infect. 2008 May;14 Suppl 4:71-83. doi: 10.1111/j.1469-0691.2008.01984.x.
8
Use of antifungal therapy in hospitalized patients. I. Results prior to the marketing of fluconazole.住院患者抗真菌治疗的应用。I. 氟康唑上市前的结果。
Ann Pharmacother. 1994 Feb;28(2):252-60. doi: 10.1177/106002809402800219.
9
Recent advances in the treatment of systemic fungal infections.系统性真菌感染治疗的最新进展。
Methods Find Exp Clin Pharmacol. 1987 Nov;9(11):769-78.
10
[New aspects in treatment of systemic mycoses].[系统性真菌病治疗的新进展]
Wien Klin Wochenschr. 1998 Nov 13;110(21):740-50.

引用本文的文献

1
Genital-oral transmission of ..的生殖器-口腔传播
Int J STD AIDS. 2025 Feb;36(2):158-160. doi: 10.1177/09564624241296582. Epub 2024 Oct 29.
2
Antimicrobial activities of Diltiazem Hydrochloride: drug repurposing approach.盐酸地尔硫䓬的抗菌活性:药物再利用方法。
PeerJ. 2024 Sep 23;12:e17809. doi: 10.7717/peerj.17809. eCollection 2024.
3
The Preliminary Analysis of Flavonoids in the Petals of , and Infected with .对感染的 、 、花瓣中的类黄酮的初步分析。

本文引用的文献

1
Amphotericins A and B, antifungal antibiotics produced by a streptomycete. I. In vitro studies.两性霉素A和B,由链霉菌产生的抗真菌抗生素。I. 体外研究。
Antibiot Annu. 1955;3:579-86.
2
Fluconazole.
Indian J Pediatr. 1996 Nov-Dec;63(6):775-80. doi: 10.1007/BF02730928.
3
Antifungals: mechanism of action and resistance, established and novel drugs.抗真菌药物:作用机制与耐药性,已上市及新型药物
Curr Opin Microbiol. 1998 Oct;1(5):547-57. doi: 10.1016/s1369-5274(98)80087-8.
Int J Mol Sci. 2024 Sep 4;25(17):9605. doi: 10.3390/ijms25179605.
4
Clinically relevant drug-drug interactions between antiretrovirals and antifungals.抗逆转录病毒药物与抗真菌药物之间具有临床意义的药物相互作用。
Expert Opin Drug Metab Toxicol. 2014 Apr;10(4):561-80. doi: 10.1517/17425255.2014.883379. Epub 2014 Feb 12.
5
Newer antifungal agents.
Indian J Pediatr. 2004 Mar;71(3):253-9. doi: 10.1007/BF02724279.
4
Antifungal agents. Part II. The azoles.抗真菌剂。第二部分。唑类。
Mayo Clin Proc. 1999 Jan;74(1):78-100. doi: 10.4065/74.1.78.
5
In vitro activities of voriconazole (UK-109,496) and four other antifungal agents against 394 clinical isolates of Candida spp.伏立康唑(UK-109,496)及其他四种抗真菌药物对394株念珠菌属临床分离株的体外活性
Antimicrob Agents Chemother. 1998 Jan;42(1):161-3. doi: 10.1128/AAC.42.1.161.
6
New antifungal therapy for children.儿童新型抗真菌疗法。
Adv Dermatol. 1997;12:195-208; discussion 209.
7
Use of amphotericin B with azole antifungal drugs: what are we doing?两性霉素B与唑类抗真菌药物联合使用:我们在做什么?
Antimicrob Agents Chemother. 1995 Sep;39(9):1907-12. doi: 10.1128/AAC.39.9.1907.
8
Food interaction and steady-state pharmacokinetics of itraconazole capsules in healthy male volunteers.伊曲康唑胶囊在健康男性志愿者中的食物相互作用及稳态药代动力学
Antimicrob Agents Chemother. 1993 Apr;37(4):778-84. doi: 10.1128/AAC.37.4.778.
9
Interaction of itraconazole and digoxin.
Clin Infect Dis. 1993 Mar;16(3):400-3. doi: 10.1093/clind/16.3.400.
10
Antifungal susceptibility testing. Current state of technology, limitations, and standardization.抗真菌药敏试验。技术现状、局限性与标准化
Infect Dis Clin North Am. 1993 Jun;7(2):435-44.